UroGen Pharma Ltd. Contracts & Agreements
58 Contracts & Agreements
- Business Finance (10 contracts)
- Business Operations (4)
- Human Resources (33)
- Intellectual Property (2)
- Real Estate (2)
- Uncategorized (7)
- Pre-Paid Forward Contract by and among the Registrant and RTW Investments ICAV for and on behalf of RTW Fund 2, dated as of March 18, 2021, as amended April 30, 2021 and August... (Filed With SEC on November 6, 2024)
- Employment Agreement between the Company and Christopher Degnan, dated October 7, 2024 (Filed With SEC on October 9, 2024)
- Separation Agreement between the Company and Don Kim, dated October 7, 2024 (Filed With SEC on October 9, 2024)
- UroGen Pharma Ltd. 2019 Inducement Plan, as amended (Filed With SEC on August 13, 2024)
- UroGen Pharma Ltd. 2017 Equity Incentive Plan (Filed With SEC on August 8, 2024)
- UroGen Pharma Ltd. 2024 Non-Employee Director and Officer Compensation Policy (Filed With SEC on August 8, 2024)
- Form of June 2024 Pre-Funded Warrant (Filed With SEC on June 18, 2024)
- Underwriting Agreement, dated June 17, 2024, by and among the Company, TD Securities (USA) LLC and Guggenheim Securities, LLC (Filed With SEC on June 18, 2024)
- Form of Performance Stock Award Grant Notice and Performance Stock Award Agreement under the UroGen Pharma Ltd. Israeli Sub-Plan to 2017 Equity Incentive Plan (Filed With SEC on May 13, 2024)
- Amendment to Form of Performance-Based Restricted Stock Unit Grant Notice under the UroGen Pharma Ltd. 2017 Equity Incentive Plan (Filed With SEC on May 13, 2024)
- Amendment to Form of Restricted Stock Unit Grant Notice under the UroGen Pharma Ltd. 2019 Inducement Plan (Filed With SEC on March 14, 2024)
- Amendment to Form of Restricted Stock Unit Grant Notice under the UroGen Pharma Ltd. 2017 Equity Incentive Plan (Filed With SEC on March 14, 2024)
- Amended Restricted Stock Unit Grant Notice by and between the Registrant and Elizabeth Barrett, dated as of December 20, 2023 (Filed With SEC on March 14, 2024)
- Amendment 2 to Manufacturing & Supply Agreement, dated as of December 28, 2023 by and between UroGen Pharma Ltd. and Cenexi-Laboratoires Thissen s.a (Filed With SEC on March 14, 2024)
- License and Supply Agreement, dated as of January 16, 2024, by and between UroGen Pharma Ltd. and Medac Gesellschaft fr klinische Spezialprparate m.b.H (Filed With SEC on March 14, 2024)
- Performance-Based Restricted Stock Unit Grant Notice by and between the Registrant and Elizabeth Barrett, dated as of November 13, 2023 (Filed With SEC on November 14, 2023)
- Form of Performance-Based Restricted Stock Unit Grant Notice and Performance-Based Restricted Stock Unit Award Agreement under the Urogen Pharma Ltd. 2017 Equity Incentive Plan (Filed With SEC on November 14, 2023)
- Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under the Urogen Pharma Ltd. 2017 Equity Incentive Plan (Filed With SEC on November 14, 2023)
- Form of Stock Option Grant Notice and Stock Option Agreement under the Urogen Pharma Ltd. 2017 Equity Incentive Plan (Filed With SEC on November 14, 2023)
- 2017 Equity Incentive Plan, as amended (Filed With SEC on November 14, 2023)
- Amendment to Loan Agreement, dated June 29, 2023, by and among the Company, UroGen Pharma, Inc., as the borrower, and certain direct and indirect subsidiaries of the Company party... (Filed With SEC on August 10, 2023)
- Manufacturing and Supply Agreement - Amendment No. 2, dated May 19, 2023, by and between the Registrant and Isotopia Molecular Imaging Ltd (Filed With SEC on August 10, 2023)
- Securities Purchase Agreement, dated July 26, 2023, by and among UroGen Pharma Ltd. and the Purchasers named therein (Filed With SEC on July 27, 2023)
- Form of July 2023 Pre-Funded Warrant (Filed With SEC on July 27, 2023)
- Amended and Restated Compensation Policy for Officer Holders (Filed With SEC on March 24, 2023)
- 2017 Equity Incentive Plan, as amended (Filed With SEC on March 24, 2023)
- Manufacturing and Supply Agreement, dated May 30, 2020, by and between the Registrant and Isotopia Molecular Imaging Ltd. (the Isotopia Agreement) and the extension to the... (Filed With SEC on November 10, 2022)
- Amendment to Lease Agreement, dated June 8, 2022, by and between the Registrant and Witman Properties, L.L.C. and Alexander Road at Davanne, L.L.C (Filed With SEC on August 11, 2022)
- UroGen Pharma Ltd. 2017 Equity Incentive Plan, as amended (Filed With SEC on June 13, 2022)
- Employment Agreement between the Company and Dong Kim, dated March 20, 2022 (Filed With SEC on March 21, 2022)
- UroGen Pharma Ltd. 2019 Inducement Plan, as amended (Filed With SEC on March 21, 2022)
- UroGen Pharma Ltd. 2017 Equity Incentive Plan, as amended (Filed With SEC on June 8, 2021)
- Pre-Paid Forward Contract by and among the Registrant and RTW Investments ICAV for and on behalf of RTW Fund 2, dated as of March 18, 2021, as amended (Filed With SEC on May 13, 2021)
- Amendment 2 to Employment Agreement between the Company and Mark Schoenberg, dated March 15, 2021 (Filed With SEC on May 13, 2021)
- Amendment 1 to Employment Agreement between the Company and Jason Smith, dated January 26, 2021 (Filed With SEC on May 13, 2021)
- Amendment 1 to Employment Agreement between the Company and Mark Schoenberg, dated January 26, 2021 (Filed With SEC on May 13, 2021)
- Amendment 1 to Employment Agreement between the Company and Elizabeth Barrett, dated January 26, 2021 (Filed With SEC on May 13, 2021)
- Omnibus Amendment to Equity Awards between the Company and Elizabeth Barrett, dated January 19, 2021 (Filed With SEC on May 13, 2021)
- Amendment No. 1 to Sales Agreement, dated as of December 20, 2019, by and between the Registrant and Cowen and Company, LLC (Filed With SEC on November 9, 2020)
- Employment Agreement between the Company and Jason Smith, dated August 12, 2020 (Filed With SEC on November 9, 2020)
- Employment Agreement between the Company and Molly Henderson, dated September 3, 2020 (Filed With SEC on September 9, 2020)
- Separation Agreement between the Company and Peter Pfreundschuh, dated September 8, 2020 (Filed With SEC on September 9, 2020)
- UroGen Pharma Ltd. 2017 Equity Incentive Plan, as amended (Filed With SEC on June 10, 2020)
- Separation Agreement between the Company and Stephen Mullennix, dated March 20, 2020 (Filed With SEC on March 23, 2020)
- Lease Agreement, dated November 4, 2019, by and between the Registrant and Witman Properties, L.L.C. and Alexander Road at Davanne, L.L.C (Filed With SEC on March 2, 2020)
- License Agreement, dated November 8, 2019, by and between the Registrant and Agenus Inc (Filed With SEC on March 2, 2020)
- Description of the Registrants Ordinary Shares (Filed With SEC on March 2, 2020)
- Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the UroGen Pharma Ltd. 2019 Inducement Plan (Filed With SEC on May 28, 2019)
- Form of Stock Option Grant Notice and Stock Option Agreement under the UroGen Pharma Ltd. 2019 Inducement Plan (Filed With SEC on May 28, 2019)
- UroGen Pharma Ltd. 2019 Inducement Plan (Filed With SEC on May 28, 2019)
- 2017 Equity Incentive Plan, as amended (Filed With SEC on February 28, 2019)
- Separation and Agreement between the Company and Gary Titus, dated as of July 11, 2018 (Filed With SEC on February 28, 2019)
- Separation and Release Agreement between the Registrant and Ron Bentsur, dated as of January 3, 2019 (Filed With SEC on February 28, 2019)
- Employment Agreement by and between the Registrant and Mark Schoenberg, dated as of December 5, 2017 (Filed With SEC on February 28, 2019)
- Employment Agreement by and between the Registrant and Stephen Mullennix, dated as of January 17, 2018 (Filed With SEC on February 28, 2019)
- Employment Agreement by and between the Registrant and Peter Pfreundschuh, dated as of July 31, 2018 (Filed With SEC on February 28, 2019)
- Employment Agreement by and between the Registrant and Elizabeth Barrett, dated as of January 3, 2019 (Filed With SEC on February 28, 2019)
- Underwriting Agreement, dated January 23, 2019 (Filed With SEC on January 25, 2019)
